Association of Body Mass Index With Care and Outcomes in Patients With Atrial Fibrillation: Results From the ORBIT-AF Registry

Ambarish Pandey, Bernard J. Gersh, Darren K McGuire, Peter Shrader, Laine Thomas, Peter R. Kowey, Kenneth W. Mahaffey, Elaine Hylek, Shining Sun, Paul Burton, Jonathan Piccini, Eric Peterson, Gregg C. Fonarow

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Objectives This study sought to determine the association between body mass index (BMI) and clinical outcomes among patients with prevalent atrial fibrillation (AF). Background Higher BMI is an independent risk factor for incident AF. However, its impact on management strategies and clinical outcomes among patients with prevalent AF is unclear. Methods Patients with AF enrolled in the ORBIT-AF (Outcomes Registry for Better Informed Treatment of Atrial Fibrillation) registry from June 2010 through August 2011 were stratified into BMI-based categories as normal weight, overweight, class I obese, class II obese, and class III obese. Unadjusted and adjusted Cox frailty models were constructed to assess the association of BMI with clinical outcomes over a 2-year follow-up. Results We evaluated 9,606 patients with AF (42% women; 78% overweight/obese) from 174 ORBIT participating practices in the United States. Higher BMI patients were younger and had a greater prevalence of diabetes, hypertension, and obstructive sleep apnea (OSA). Use of anticoagulation and rhythm control strategies was significantly greater among higher BMI patients. Rates for all-cause mortality and thromboembolic events decreased in a near linear fashion across increasing BMI categories (p <0.001). After multivariable adjustment, higher BMI was associated with lower risk for all-cause mortality with lowest risk among class I obese patients (hazard ratio [HR]: 0.65; 95% CI: 0.54 to 0.78); reference: normal weight). For every 5-kg/m2 increase in BMI, the odds of risk-adjusted mortality were 7% lower. In contrast, BMI was not associated with adjusted risk for thromboembolic events and AF progression. Conclusions Although AF patients with higher BMI were significantly younger, higher BMI in AF patients was associated with similar or better clinical outcomes.

Original languageEnglish (US)
Pages (from-to)355-363
Number of pages9
JournalJACC: Clinical Electrophysiology
Volume2
Issue number3
DOIs
StatePublished - 2016

Fingerprint

Atrial Fibrillation
Registries
Body Mass Index
Therapeutics
Mortality
Weights and Measures
Obstructive Sleep Apnea
Proportional Hazards Models
Hypertension

Keywords

  • atrial fibrillation
  • body mass index
  • mortality
  • stroke

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Cite this

Association of Body Mass Index With Care and Outcomes in Patients With Atrial Fibrillation : Results From the ORBIT-AF Registry. / Pandey, Ambarish; Gersh, Bernard J.; McGuire, Darren K; Shrader, Peter; Thomas, Laine; Kowey, Peter R.; Mahaffey, Kenneth W.; Hylek, Elaine; Sun, Shining; Burton, Paul; Piccini, Jonathan; Peterson, Eric; Fonarow, Gregg C.

In: JACC: Clinical Electrophysiology, Vol. 2, No. 3, 2016, p. 355-363.

Research output: Contribution to journalArticle

Pandey, A, Gersh, BJ, McGuire, DK, Shrader, P, Thomas, L, Kowey, PR, Mahaffey, KW, Hylek, E, Sun, S, Burton, P, Piccini, J, Peterson, E & Fonarow, GC 2016, 'Association of Body Mass Index With Care and Outcomes in Patients With Atrial Fibrillation: Results From the ORBIT-AF Registry', JACC: Clinical Electrophysiology, vol. 2, no. 3, pp. 355-363. https://doi.org/10.1016/j.jacep.2015.12.001
Pandey, Ambarish ; Gersh, Bernard J. ; McGuire, Darren K ; Shrader, Peter ; Thomas, Laine ; Kowey, Peter R. ; Mahaffey, Kenneth W. ; Hylek, Elaine ; Sun, Shining ; Burton, Paul ; Piccini, Jonathan ; Peterson, Eric ; Fonarow, Gregg C. / Association of Body Mass Index With Care and Outcomes in Patients With Atrial Fibrillation : Results From the ORBIT-AF Registry. In: JACC: Clinical Electrophysiology. 2016 ; Vol. 2, No. 3. pp. 355-363.
@article{67c7540ea6bc441e9b8f221ec95d1a5a,
title = "Association of Body Mass Index With Care and Outcomes in Patients With Atrial Fibrillation: Results From the ORBIT-AF Registry",
abstract = "Objectives This study sought to determine the association between body mass index (BMI) and clinical outcomes among patients with prevalent atrial fibrillation (AF). Background Higher BMI is an independent risk factor for incident AF. However, its impact on management strategies and clinical outcomes among patients with prevalent AF is unclear. Methods Patients with AF enrolled in the ORBIT-AF (Outcomes Registry for Better Informed Treatment of Atrial Fibrillation) registry from June 2010 through August 2011 were stratified into BMI-based categories as normal weight, overweight, class I obese, class II obese, and class III obese. Unadjusted and adjusted Cox frailty models were constructed to assess the association of BMI with clinical outcomes over a 2-year follow-up. Results We evaluated 9,606 patients with AF (42{\%} women; 78{\%} overweight/obese) from 174 ORBIT participating practices in the United States. Higher BMI patients were younger and had a greater prevalence of diabetes, hypertension, and obstructive sleep apnea (OSA). Use of anticoagulation and rhythm control strategies was significantly greater among higher BMI patients. Rates for all-cause mortality and thromboembolic events decreased in a near linear fashion across increasing BMI categories (p <0.001). After multivariable adjustment, higher BMI was associated with lower risk for all-cause mortality with lowest risk among class I obese patients (hazard ratio [HR]: 0.65; 95{\%} CI: 0.54 to 0.78); reference: normal weight). For every 5-kg/m2 increase in BMI, the odds of risk-adjusted mortality were 7{\%} lower. In contrast, BMI was not associated with adjusted risk for thromboembolic events and AF progression. Conclusions Although AF patients with higher BMI were significantly younger, higher BMI in AF patients was associated with similar or better clinical outcomes.",
keywords = "atrial fibrillation, body mass index, mortality, stroke",
author = "Ambarish Pandey and Gersh, {Bernard J.} and McGuire, {Darren K} and Peter Shrader and Laine Thomas and Kowey, {Peter R.} and Mahaffey, {Kenneth W.} and Elaine Hylek and Shining Sun and Paul Burton and Jonathan Piccini and Eric Peterson and Fonarow, {Gregg C.}",
year = "2016",
doi = "10.1016/j.jacep.2015.12.001",
language = "English (US)",
volume = "2",
pages = "355--363",
journal = "JACC: Clinical Electrophysiology",
issn = "2405-5018",
publisher = "Elsevier USA",
number = "3",

}

TY - JOUR

T1 - Association of Body Mass Index With Care and Outcomes in Patients With Atrial Fibrillation

T2 - Results From the ORBIT-AF Registry

AU - Pandey, Ambarish

AU - Gersh, Bernard J.

AU - McGuire, Darren K

AU - Shrader, Peter

AU - Thomas, Laine

AU - Kowey, Peter R.

AU - Mahaffey, Kenneth W.

AU - Hylek, Elaine

AU - Sun, Shining

AU - Burton, Paul

AU - Piccini, Jonathan

AU - Peterson, Eric

AU - Fonarow, Gregg C.

PY - 2016

Y1 - 2016

N2 - Objectives This study sought to determine the association between body mass index (BMI) and clinical outcomes among patients with prevalent atrial fibrillation (AF). Background Higher BMI is an independent risk factor for incident AF. However, its impact on management strategies and clinical outcomes among patients with prevalent AF is unclear. Methods Patients with AF enrolled in the ORBIT-AF (Outcomes Registry for Better Informed Treatment of Atrial Fibrillation) registry from June 2010 through August 2011 were stratified into BMI-based categories as normal weight, overweight, class I obese, class II obese, and class III obese. Unadjusted and adjusted Cox frailty models were constructed to assess the association of BMI with clinical outcomes over a 2-year follow-up. Results We evaluated 9,606 patients with AF (42% women; 78% overweight/obese) from 174 ORBIT participating practices in the United States. Higher BMI patients were younger and had a greater prevalence of diabetes, hypertension, and obstructive sleep apnea (OSA). Use of anticoagulation and rhythm control strategies was significantly greater among higher BMI patients. Rates for all-cause mortality and thromboembolic events decreased in a near linear fashion across increasing BMI categories (p <0.001). After multivariable adjustment, higher BMI was associated with lower risk for all-cause mortality with lowest risk among class I obese patients (hazard ratio [HR]: 0.65; 95% CI: 0.54 to 0.78); reference: normal weight). For every 5-kg/m2 increase in BMI, the odds of risk-adjusted mortality were 7% lower. In contrast, BMI was not associated with adjusted risk for thromboembolic events and AF progression. Conclusions Although AF patients with higher BMI were significantly younger, higher BMI in AF patients was associated with similar or better clinical outcomes.

AB - Objectives This study sought to determine the association between body mass index (BMI) and clinical outcomes among patients with prevalent atrial fibrillation (AF). Background Higher BMI is an independent risk factor for incident AF. However, its impact on management strategies and clinical outcomes among patients with prevalent AF is unclear. Methods Patients with AF enrolled in the ORBIT-AF (Outcomes Registry for Better Informed Treatment of Atrial Fibrillation) registry from June 2010 through August 2011 were stratified into BMI-based categories as normal weight, overweight, class I obese, class II obese, and class III obese. Unadjusted and adjusted Cox frailty models were constructed to assess the association of BMI with clinical outcomes over a 2-year follow-up. Results We evaluated 9,606 patients with AF (42% women; 78% overweight/obese) from 174 ORBIT participating practices in the United States. Higher BMI patients were younger and had a greater prevalence of diabetes, hypertension, and obstructive sleep apnea (OSA). Use of anticoagulation and rhythm control strategies was significantly greater among higher BMI patients. Rates for all-cause mortality and thromboembolic events decreased in a near linear fashion across increasing BMI categories (p <0.001). After multivariable adjustment, higher BMI was associated with lower risk for all-cause mortality with lowest risk among class I obese patients (hazard ratio [HR]: 0.65; 95% CI: 0.54 to 0.78); reference: normal weight). For every 5-kg/m2 increase in BMI, the odds of risk-adjusted mortality were 7% lower. In contrast, BMI was not associated with adjusted risk for thromboembolic events and AF progression. Conclusions Although AF patients with higher BMI were significantly younger, higher BMI in AF patients was associated with similar or better clinical outcomes.

KW - atrial fibrillation

KW - body mass index

KW - mortality

KW - stroke

UR - http://www.scopus.com/inward/record.url?scp=84979205219&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84979205219&partnerID=8YFLogxK

U2 - 10.1016/j.jacep.2015.12.001

DO - 10.1016/j.jacep.2015.12.001

M3 - Article

C2 - 29766895

AN - SCOPUS:84979205219

VL - 2

SP - 355

EP - 363

JO - JACC: Clinical Electrophysiology

JF - JACC: Clinical Electrophysiology

SN - 2405-5018

IS - 3

ER -